MusclePharm Ret. on equity
What is the Ret. on equity of MusclePharm?
The Ret. on equity of MusclePharm Corp. is 60.99%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Consumer Staples sector on OTC compared to MusclePharm
What does MusclePharm do?
MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.
Companies with ret. on equity similar to MusclePharm
- ADVFN Plc has Ret. on equity of 60.62%
- Global Crossing Airlines has Ret. on equity of 60.68%
- Feishang Anthracite Resources has Ret. on equity of 60.72%
- Lilly(Eli) & Co has Ret. on equity of 60.72%
- Games Workshop Plc has Ret. on equity of 60.82%
- Kenon Ltd has Ret. on equity of 60.91%
- MusclePharm has Ret. on equity of 60.99%
- Emmaus Life Sciences Incorporation has Ret. on equity of 61.00%
- Origin Agritech has Ret. on equity of 61.11%
- BEST Inc has Ret. on equity of 61.11%
- Enzo Biochem has Ret. on equity of 61.16%
- PharmaSGP SE has Ret. on equity of 61.23%
- Sociedad Quimica Y Minera de Chile S.A has Ret. on equity of 61.39%